Clinical Trial: Comparison of Efficacy of Topical Westerhoff Formula Cream Vs Topical 4% Hydroquinone for the Treatment of Melasma

U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT07508098) titled 'Comparison of Efficacy of Topical Westerhoff Formula Cream Vs Topical 4% Hydroquinone for the Treatment of Melasma' on March 27.

Brief Summary: study was conducted on middle aged male and female, including families and health care professional also.

Study Start Date: July 18, 2025

Study Type: INTERVENTIONAL

Condition: Melasma (Facial Melasma)

Intervention: DRUG: Triple combination cream

4.7% N-acetylcysteine, 2% Hydroquinone and 0.1 % triamcinolone acetate twice daily for 8 weeks

DRUG: Hydroquinone 4% Cream

twice daily for 8 weeks

Recruitment Status: COMPLETED

Sponsor: Pak Emirates Military Hospital

Information provided ...